The Oxford University/AstraZeneca vaccine is safe and effective, independent analysis has confirmed.
They hope the vaccine will be approved for use in the UK “within the coming weeks”.
Professor Andrew Pollard, director of the Oxford Vaccine Group and Chief Investigator of the Oxford Vaccine Trial, said: “Today, we have published the interim analysis of the phase III trial and show that this new vaccine has a good safety record and efficacy against the coronavirus.
“We are hugely grateful to our trial volunteers for working with us over the past eight months to bring us to this milestone.”
The vaccine is both simple and cheap to produce, and can be manufactured in large quantities at low cost.
Unlike the Pfizer/BioNTech vaccine, it does not need to be kept at ultra low temperatures, meaning that it will be much more easily accessed in all parts of the world.